As the pathological immune response in HDFN can arise early in gestation and persist throughout a pregnancy, dosing of FcRn antagonists to treat HDFN would have to be continuously performed throughout gestation
Oral Larazotide: Tight Junction Support for Leaky Gut and Celiac Disease The larazotide peptide specifically targets intestinal tight junctions, helping to reduce gut permeability and preventing the leakage of toxins into the bloodstream
BPC-157: 0.25-0.5 mg daily subcutaneous TB-500: Loading phase 2.5 mg twice weekly for weeks 1-4, then maintenance 2-3 mg weekly Duration: 6-8 weeks concurrent use Note: Administer separately
ClinicalTrials.gov Rosenstock J, Frias JP, Jastreboff AM, et al
Cycling (taking breaks between protocols) is recommended for longer-term healing goals
Vitamin B12 Toxicity Some people might worry that they are getting too much vitamin B12